by Michael Fenimore | Jun 10, 2022 | Uncategorized
Renal cell carcinoma (RCC) remains the most common variety of renal cancer, representing 90% of the diagnoses. Within the United States (US), it is a relatively common malignant caner, ranking as sixth and tenth most common for men and women respectively. Yet, the...
by Michael Fenimore | May 30, 2022 | Pulmonology
This research study will explore current and future practices, beliefs, and priorities of health professionals treating COPD in order to identify their educational needs and interests. The study is conducted in the setting of small, peer-led digital groups of...
by Michael Fenimore | May 5, 2022 | Uncategorized
This CME/CE/CPE-certified activity has been developed to bring together different members of the breast cancer care team in small-group virtual workshops that allow interactions through various collaborative educational experiences. The goal of this activity is to...
by Michael Fenimore | Apr 14, 2022 | Uncategorized
This program is designed to offer an expert-led interactive approach to providing optimal care for patients with acute myeloid leukemia (AML). Topics discussed will include creating and implementing multidisciplinary, evidence-based, and patient-specific plans for the...
by Michael Fenimore | Mar 22, 2022 | Uncategorized
The current treatment of advanced, recurrent, and metastatic cervical cancer is difficult, especially as treatment progresses to the second line. Considerations for treatment are nuanced and numerous. Factors include prior treatments, treatment timing, and patient...
